OpenVSafe by OpenVAERS
Search V-safe

9B3-29806-54964

3 vaccinations 6 coded responses 27 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
947 / CA
Registered
2021-03-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-26
    Registered in v-safe
  2. 2021-03-26
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-26
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-03-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Abdominal pain
    Adult check-in
  6. 2021-03-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  7. 2021-03-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  8. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-04-02
    Health check-in — day 7, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2021-04-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-04-17
    Dose 2 — Pfizer-BioNTech
  13. 2021-04-17
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · None
    Adult check-in
  14. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain
    Free text: Lymph node under the injection site arm is painful and swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair
    Free text: swollen and sore lymph node in armpit of injected arm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  19. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-05-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-08
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-22
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-29
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-17
    Survey response — 3 months, dose 2
    MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school
    Free text: I have a cold
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-12-12
    Dose 3 — Moderna
  29. 2022-04-17
    Survey response — 12 months, dose 2
    MedDRA: Adverse reaction, Migraine, Photophobia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I don't normally get migraines but my COVID booster triggered about a week and a half of severe migraines with sensitivity to light in addition to the typical symptoms. I've had the occasional migraine since then
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-06-14
    Survey response — 6 months, dose 3
    MedDRA: Oral candidiasis, Pyrexia, Respiratory symptom, SARS-CoV-2 test positive, Tongue discolouration — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I tested positive for COVID on May 31, 2022 and had fever and moderate respiratory symptoms. It also caused white dots on my tongue which I think is oral thrush
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-12-12
    Survey response — 12 months, dose 3
    MedDRA: Pityriasis rosea — Feeling: Good
    Free text: rash (pityriasis rosea)
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-26Pfizer-BioNTech
22021-04-17Pfizer-BioNTech
32021-12-12Moderna No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): Lymph node under the injection site arm is painful and swollen

2021-04-20

Systemic reaction (other): swollen and sore lymph node in armpit of injected arm

Release 9 — 3 months, dose 2

2021-07-17

Symptoms: I have a cold

Release 11 — 12 months, dose 2

2022-04-17

Symptoms: I don't normally get migraines but my COVID booster triggered about a week and a half of severe migraines with sensitivity to light in addition to the typical symptoms. I've had the occasional migraine since then

Release 12 — 6 months, dose 3

2022-06-14

Symptoms: I tested positive for COVID on May 31, 2022 and had fever and moderate respiratory symptoms. It also caused white dots on my tongue which I think is oral thrush

Release 12 — 12 months, dose 3

2022-12-12

Symptoms: rash (pityriasis rosea)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse reaction · · ✓
SDMigraine · · ✓
SDNasopharyngitis · · ✓
SDOral candidiasis · · ✓
SDPhotophobia · · ✓
SDPityriasis rosea · · ✓
SDPyrexia · · ✓
SDRespiratory symptom · · ✓
SDSARS-CoV-2 test positive · · ✓
SDTongue discolouration · · ✓
SROLymph node pain ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release